Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 5, 2020

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
Autism Spectrum DisorderAttention-deficit Hyperactivity Disorder
Interventions
OTHER

Interview by psychologists

"Interviews for children / teenagers and parents :~* The questions encourage a narrative~* Repeated interviews: during confinement, at the end of confinement, and 3 months after the end of confinement~* Interviews carried out by videoconference, by trained psychologists not involved in the care process~Interview for referring caregivers: a single interview of approximately 45 minutes, 3 months post-confinement"

Trial Locations (5)

31059

University hospital of Toulouse, Toulouse

75019

Hôpital Robert-Debré (AP-HP), Paris

75679

Maison de Solenn (Hôpital Cochin AP-HP), Paris

78157

Centre Hospitalier de Versailles, Le Chesnay

87025

Centre Hospitalier Esquirol, Limoges

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Toulouse

OTHER

NCT04416360 - Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak | Biotech Hunter | Biotech Hunter